高级检索
当前位置: 首页 > 详情页

Prevalence of Cardiovascular Disease and Risk Factors in the Chinese Population with Impaired Glucose Regulation: the 2007-2008 China National Diabetes and Metabolic Disorders Study

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]China Japan Friendship Hosp, Beijing 100029, Peoples R China [2]Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China [3]Sun Yat Sen Univ, Hosp 3, Guangzhou 510275, Guangdong, Peoples R China [4]Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China [5]Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China [6]Chinese Med Univ, Affiliated Hosp 1, Liaoling, Peoples R China [7]Shanxi Prov Peoples Hosp, Taiyuan, Shanxi, Peoples R China [8]Sichuan Univ, West China Hosp, Chengdu 610064, Sichuan, Peoples R China [9]Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shanxi, Peoples R China [10]Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China [11]Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China [12]Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China [13]Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China [14]Peking Univ, Hosp 1, Beijing 100871, Peoples R China [15]Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China [16]Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China [17]Xiangya Second Hosp, Changsha, Hunan, Peoples R China [18]Peking Union Med Coll, Beijing 100021, Peoples R China
出处:
ISSN:

关键词: diabetes cardiovascular risk management metabolic features

摘要:
Aims: Cardiovascular disease (CVD) is one of the most common chronic diseases in China. This aim of this study is to determine the prevalence of CVDs and risk factors in Chinese impaired glucose regulation subjects. Methods: We used a multistage, stratified sampling method to select subjects from the general Chinese population aged 20 years and older. Subjects underwent an oral glucose tolerance test to identify normal glucose tolerance (NGT) and impaired glucose regulation including isolated impaired fasting glucose (i-IFG), impaired glucose tolerance (i-IGT), and combined IFG/IGT and diabetic mellitus (DM). A logistic regression analysis was performed to examine the association between glucose abnormalities and CVD events. Results: We identified that 34 293 subjects had NGT, 1 469 i-IFG, 4 571 i-IGT, 957 IFG/IGT and 4 949 DM. The age-sex standardized prevalence rate of cardiovascular disease was 1.06% (95% CI 0.87-1.28), 1.79% (95% CI 1.37-2.33) and 3.83% (95% CI 2.79-5.24) in NGT, impaired glucose regulation and DM, respectively. Among impaired glucose subjects, prevalence of defined CVD risk factors (smoking, overweight, obesity, hypertension and dyslipidemia) was 29.52% (95% CI: 27.8-31.21), 36.25% (95% CI: 34.29-38.26), 10.05% (95% CI: 8.86-11.37), 36.43% (95% CI: 34.53-38.36) and 69.96% (95% CI: 67.87-71.98), respectively. Compared to 1 risk factor, the odds ratios (ORs) of CVDs with 2, 3 or 4 risk factors were 1.94 (95% CI: 0.74-5.09), 2.76 (95% CI: 1.06-7.21) and 5.84 (95% CI: 1.68-20.26), respectively. Additionally, compared to i-IFGs, ORs of CVDs with i-IGT and IFG/IGT were 2.88 (95% CI 1.36-6.01) and 2.12 (95% CI 0.83-5.44), respectively. Conclusion: The prevalence of cardiovascular risk factors was high in the Chinese impaired glucose regulation population. The postprandial hyperglycemia is more associated with CVD than isolated fasting hyperglycemia.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢
JCR分区:
出版当年[2011]版:
Q3 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q4 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2011版] 出版当年五年平均[2007-2011] 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者单位: [1]China Japan Friendship Hosp, Beijing 100029, Peoples R China
通讯作者:
通讯机构: [1]China Japan Friendship Hosp, Beijing 100029, Peoples R China [*1]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)